메뉴 건너뛰기




Volumn 2, Issue 7, 2006, Pages 19-22

Combined modality treatment for early-stage Hodgkin's lymphoma: The GHSG experience

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

EID: 46849099450     PISSN: 18249337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (15)
  • 1
    • 46849093207 scopus 로고    scopus 로고
    • Diehl V, Mauch P, Harris NL: Hodgkin's Disease. In: De Vita V, ed. Cancer Principles and Practice of Oncology. Philadelphia, PA 19106 USA, Lippincott Williams & Wilkins 2001;pp 2339-2387.
    • Diehl V, Mauch P, Harris NL: Hodgkin's Disease. In: De Vita V, ed. Cancer Principles and Practice of Oncology. Philadelphia, PA 19106 USA, Lippincott Williams & Wilkins 2001;pp 2339-2387.
  • 2
    • 0030804040 scopus 로고    scopus 로고
    • Survival analysis of patients with clinical stages I or II Hodgkin's disease who have relapsed after initial treatment with radiotherapy alone
    • Horwich A, Specht L, Ashley S. Survival analysis of patients with clinical stages I or II Hodgkin's disease who have relapsed after initial treatment with radiotherapy alone. Eur J Cancer 1997;33, 848-53.
    • (1997) Eur J Cancer , vol.33 , pp. 848-853
    • Horwich, A.1    Specht, L.2    Ashley, S.3
  • 3
    • 0035890435 scopus 로고    scopus 로고
    • Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease
    • Press OW, LeBlanc M, Lichter AS, Grogan TM, Unger JM, Wasserman TH, et al. Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease. J Clin Oncol 2001;19:4238-44.
    • (2001) J Clin Oncol , vol.19 , pp. 4238-4244
    • Press, O.W.1    LeBlanc, M.2    Lichter, A.S.3    Grogan, T.M.4    Unger, J.M.5    Wasserman, T.H.6
  • 4
    • 21044441109 scopus 로고    scopus 로고
    • Very brief (8 week) chemotherapy (CT) and low dose (30 Gy) radiotherapy (RT) for limited stage Hodgkin's disease (HD): Preliminary results of the Stanford-Kaiser G4 Study of Stanford V + RT
    • abstract
    • Horning SJ, Hoppe RT, Breslin S, Baer DM, Mason J, Rosenberg SA. Very brief (8 week) chemotherapy (CT) and low dose (30 Gy) radiotherapy (RT) for limited stage Hodgkin's disease (HD): preliminary results of the Stanford-Kaiser G4 Study of Stanford V + RT. Blood 1999;94,1717a [abstract].
    • (1999) Blood
    • Horning, S.J.1    Hoppe, R.T.2    Breslin, S.3    Baer, D.M.4    Mason, J.5    Rosenberg, S.A.6
  • 5
    • 4344699405 scopus 로고    scopus 로고
    • ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: Long-term results
    • Bonadonna G, Bonfante V, Viviani S, Di Russo A, Villani F, Valagussa, P. ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results. J Clin Oncol 2004;22:2835-41.
    • (2004) J Clin Oncol , vol.22 , pp. 2835-2841
    • Bonadonna, G.1    Bonfante, V.2    Viviani, S.3    Di Russo, A.4    Villani, F.5    Valagussa, P.6
  • 6
    • 0001904827 scopus 로고    scopus 로고
    • Superiority of EBVP chemotherapy with involved field irradiation over subtotal nodal irradiation in favourable clinical stage I-II Hodgkin's disease: The EORTCGPMC H7F randomised trial
    • Carde P, Noordijk E, Hagenbek A. Superiority of EBVP chemotherapy with involved field irradiation over subtotal nodal irradiation in favourable clinical stage I-II Hodgkin's disease: the EORTCGPMC H7F randomised trial. Pro ASCO 1997;16:13.
    • (1997) Pro ASCO , vol.16 , pp. 13
    • Carde, P.1    Noordijk, E.2    Hagenbek, A.3
  • 7
    • 0012411103 scopus 로고    scopus 로고
    • Three cycles of MOPP/ABV hybrid and involved-field irradiation in favourable supradiaphragmatic clinical stages I-II Hodgkin's disease: Preliminary results of the EORTC-GELA H8F randomised trial in 543 patients
    • abstract
    • Hagenbeek A, Eghbali H, Fermé C. Three cycles of MOPP/ABV hybrid and involved-field irradiation in favourable supradiaphragmatic clinical stages I-II Hodgkin's disease: preliminary results of the EORTC-GELA H8F randomised trial in 543 patients. Blood 2000;96, 676a [abstract].
    • (2000) Blood , vol.96
    • Hagenbeek, A.1    Eghbali, H.2    Fermé, C.3
  • 8
    • 0346125869 scopus 로고    scopus 로고
    • Two cycles of ABVD plus extented field radiotherapy is superior to radiotherapy alone in early stage Hodgkin's disease: Results of the German Hodgkin's Lymphoma Study Group (GHSG) trial HD7
    • abstract
    • Sieber M, Franklin J, Tesch H, Rueffer U, Brillant C, Reineke T, et al. Two cycles of ABVD plus extented field radiotherapy is superior to radiotherapy alone in early stage Hodgkin's disease: results of the German Hodgkin's Lymphoma Study Group (GHSG) trial HD7. Blood 2002;100, 341a [abstract].
    • (2002) Blood , vol.100
    • Sieber, M.1    Franklin, J.2    Tesch, H.3    Rueffer, U.4    Brillant, C.5    Reineke, T.6
  • 9
    • 33646811123 scopus 로고    scopus 로고
    • HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin's lymphoma. Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG)
    • abstract
    • Diehl V, Brillant C, Engert A, Mueller RP, Mueller-Hermelink HK, Herrmann R, et al. HD10: investigating reduction of combined modality treatment intensity in early stage Hodgkin's lymphoma. Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG). J Clin Oncol 2005;23, 6506a [abstract].
    • (2005) J Clin Oncol , vol.23
    • Diehl, V.1    Brillant, C.2    Engert, A.3    Mueller, R.P.4    Mueller-Hermelink, H.K.5    Herrmann, R.6
  • 10
    • 0021963461 scopus 로고
    • Extended versus involved field irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease
    • Zittoun R, Audebert A, Hoerni B, Bernadou A, Krulik M, Rojouan J et al. Extended versus involved field irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease. J Clin Oncol 1985;3, 207-14.
    • (1985) J Clin Oncol , vol.3 , pp. 207-214
    • Zittoun, R.1    Audebert, A.2    Hoerni, B.3    Bernadou, A.4    Krulik, M.5    Rojouan, J.6
  • 11
    • 4243633257 scopus 로고    scopus 로고
    • MOPP/ABV (M/A) hybrid and irradiation in unfavourable supradiaphragmatic clinical stages III HD: Comparison of three treatment modalities, preliminary results of the EORTC-GELA H8-U randomized trial in 995 patients
    • abstract
    • Ferme C, Eghbali H, Hagenbeek A. MOPP/ABV (M/A) hybrid and irradiation in unfavourable supradiaphragmatic clinical stages III HD: comparison of three treatment modalities, preliminary results of the EORTC-GELA H8-U randomized trial in 995 patients. Blood 2000;96, 576a [abstract].
    • (2000) Blood , vol.96
    • Ferme, C.1    Eghbali, H.2    Hagenbeek, A.3
  • 12
    • 0141939066 scopus 로고    scopus 로고
    • German Hodgkin's Lymphoma Study Group. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavourable Hodgkin's lymphoma: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group
    • Engert A, Schiller P, Josting A, Herrmann R, Koch P, Sieber, M, et al. German Hodgkin's Lymphoma Study Group. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavourable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group. J Clin Oncol 2003;21, 3601-8.
    • (2003) J Clin Oncol , vol.21 , pp. 3601-3608
    • Engert, A.1    Schiller, P.2    Josting, A.3    Herrmann, R.4    Koch, P.5    Sieber, M.6
  • 13
    • 0026439199 scopus 로고    scopus 로고
    • Canellos, GP, Anderson, JR, Propert KJ, Nissen N, Cooper MR, Henderson ES, et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med1992;327, 1478-84.
    • Canellos, GP, Anderson, JR, Propert KJ, Nissen N, Cooper MR, Henderson ES, et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med1992;327, 1478-84.
  • 14
    • 24944460608 scopus 로고    scopus 로고
    • Final results of the EORTC-GELA H9 randomized trials: The H9-F trial (comparing 3 radiation dose levels) and H9-U trial (comparing 3 chemotherapy schemes) in patients with favourable or unfavourable early stage Hodgkin's lymphoma
    • abstract
    • Nordijk EM, Thomas J, Fermè C, van't Veer MB, Brice P, Divinè M, et al. Final results of the EORTC-GELA H9 randomized trials: the H9-F trial (comparing 3 radiation dose levels) and H9-U trial (comparing 3 chemotherapy schemes) in patients with favourable or unfavourable early stage Hodgkin's lymphoma. J Clin Oncol 2005;23:6505a [abstract].
    • (2005) J Clin Oncol , vol.23
    • Nordijk, E.M.1    Thomas, J.2    Fermè, C.3    van't Veer, M.B.4    Brice, P.5    Divinè, M.6
  • 15
    • 24944453433 scopus 로고    scopus 로고
    • Comparison of BEACOPP and ABVD chemotherapy in intermediate stage Hodgkin's lymphoma: Results of the fourth interim analysis of the HD 11 trial of the GHSG
    • abstract
    • Klimm B, Engert A, Brillant C, Eich HT, Mueller-Hermelink HK, HermannR, et al. Comparison of BEACOPP and ABVD chemotherapy in intermediate stage Hodgkin's lymphoma: results of the fourth interim analysis of the HD 11 trial of the GHSG. J Clin Oncol, 2005;23, 6507a [abstract].
    • (2005) J Clin Oncol , vol.23
    • Klimm, B.1    Engert, A.2    Brillant, C.3    Eich, H.T.4    Mueller-Hermelink, H.K.5    HermannR6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.